Tus kws kho mob
QP80-23 Blue Cross Response to Medical Oncology Drug Shortage of Cisplatin and Carboplatin
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2121 - 2130 ntawm 4179
Tus kws kho mob
QP81-23 Update: Medical Drug Update for Tofersen (Qalsody), Delandistrogene Moxeparvovec (Elevidys), and Donislecel (Lantidra)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP82-23 Commercial Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Izervay™, and Veopoz™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP84-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP85-23 MHCP Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Elrexfio™, Izervay™, Talvey™, and Veopoz™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP86-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP87-23 Availity Essentials Updated Claim Entry Forms
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Daim Ntawv Yuav Tshuaj thiab Chaw Muag Tshuaj
Tus kws kho mob
policyii-174-med-drug-eval-process-list-2023-1001.pdf